Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.23.2
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Concentration Risk [Line Items]        
Revenues $ 83,635 $ 103,376 $ 155,797 $ 183,761
U.S. revenue        
Concentration Risk [Line Items]        
Revenues 60,343 65,935 113,533 118,379
Non-U.S. revenue        
Concentration Risk [Line Items]        
Revenues $ 23,292 $ 37,441 $ 42,264 $ 65,382